Literature DB >> 8179342

Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.

P Paquet1, A Nikkels, J E Arrese, A Vanderkelen, G E Piérard.   

Abstract

BACKGROUND: We studied the immunopathologic characteristics of five cases of toxic epidermal necrolysis by using a large panel of antibodies. OBSERVATIONS: The pattern and amount of the inflammatory cell infiltrate varied according to the stage of the disease. The main constant feature was the prominent involvement of the monocyte-macrophage lineage, including factor XIIIa+HLA-DR+ dendrocytes and CD68+ Mac 387+ macrophages, before and during the epidermal necrosis. The number of CD4+ and CD8+ lymphocytes was comparatively small. This was associated with a dense labeling of the epidermis for tumor necrosis factor alpha.
CONCLUSIONS: Cells of the monocyte-macrophage lineage largely outnumber lymphocytes in the lesions of toxic epidermal necrolysis. Tumor necrosis factor alpha is likely a major cytokine that is responsible for necrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8179342

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  22 in total

1.  Early pathological features of the cornea in toxic epidermal necrolysis.

Authors:  G P Williams; H S Mudhar; M Leyland
Journal:  Br J Ophthalmol       Date:  2007-03-14       Impact factor: 4.638

2.  Toxic epidermal necrolysis induced by a triple-drug regimen for helicobacter pylori eradication.

Authors:  Yoshihiro Matsukawa; Hiroyuki Hara; Masanori Aoki; Kentaro Inada; Motohide Kaneko; Ko Mitamura; Umihiko Sawada; Shigemasa Sawada; Takashi Horie; Toyoko Ochiai
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

3.  RIPping the Skin Apart: Necroptosis Signaling in Toxic Epidermal Necrolysis.

Authors:  Diana Panayotova-Dimitrova; Maria Feoktistova; Martin Leverkus
Journal:  J Invest Dermatol       Date:  2015-08       Impact factor: 8.551

4.  Current understanding of delayed anticonvulsant hypersensitivity reactions.

Authors:  Gregory Krauss
Journal:  Epilepsy Curr       Date:  2006 Mar-Apr       Impact factor: 7.500

5.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

6.  Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors.

Authors:  L Le Cleach; S Delaire; L Boumsell; M Bagot; I Bourgault-Villada; A Bensussan; J C Roujeau
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

Review 7.  Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Elizabeth Shay; Ahmad Kheirkhah; Lingyi Liang; Hossam Sheha; Darren G Gregory; Scheffer C G Tseng
Journal:  Surv Ophthalmol       Date:  2009-08-21       Impact factor: 6.048

8.  Understanding Immune Responses to Surgical Transplant Procedures in Stevens Johnsons Syndrome Patients.

Authors:  Matias Soifer; Hazem M Mousa; Robert B Levy; Victor L Perez
Journal:  Front Med (Lausanne)       Date:  2021-05-21

9.  Toxic Epidermal Necrolysis and Graft-versus-Host Reaction: Revisiting a Puzzling Similarity.

Authors:  G E Piérard; T Hermanns-Lê; P Paquet; A F Rousseau; P Delvenne; C Piérard-Franchimont
Journal:  ISRN Dermatol       Date:  2013-06-03

Review 10.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.